Coronavirus Latest News

US lifts pause on Johnson & Johnson vaccine after advisers say benefits outweigh risk

The vaccine was temporarily halted while scientists investigated rare but dangerous blood clots

US health officials have lifted an 11-day pause on Johnson & Johnson vaccinations following a recommendation by an expert panel. Advisers to the Centers for Disease Control and Prevention said Friday the benefits of the single-dose Covid-19 shot outweigh a rare risk of blood clots.

Panel members said it is critical that younger women be told about that risk so they can decide if they’d rather choose another vaccine. The CDC and Food and Drug Administration agreed. European regulators earlier this week made a similar decision, deciding the clot risk was small enough to allow the rollout of Johnson & Johnson’s shot.

Continue reading…

Read the original article at The Guardian

Related Articles

Back to top button